Anlotinib Combined With Docetaxel for Advanced Non-Small Cell Lung Cancer（ALTER-L034）
Conditions
- Non Small Cell Lung Cancer
Interventions
- DRUG: Anlotinib Hydrochloride plus Docetaxel
Sponsor
The Affiliated Hospital of Qingdao University
Collaborators